Day: June 1, 2023

Pet Care Industry to Worth USD 368.88 Billion by 2030 | With a 5.92% CAGR

Written by Customer Service on June 1, 2023. Posted in Mergers And Acquisitions.

The global pet care industry covered major segments by Product Type (Pet Food Products, Veterinary Care, and Others), by Pet Type (Dog, Cat, and Others), Distribution Channel (Online and Offline), and Regional Forecast, and Others. Pune, India, June 01, 2023 (GLOBE NEWSWIRE) — The global pet care industry was valued at USD 235.32 billion in 2022. The market is poised to expand from USD 246.66 billion in 2023 to USD 368.88 billion in 2030, exhibiting a CAGR of 5.92% over the forecast period. The rise can be attributed to the escalating popularity of pet care products across numerous regions. Fortune Business Insights™ cites this information in its research report, titled “Pet Care Market Size, Share & Forecast 2023-2030”. Get a Free Sample Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pet-care-market-104749 List...

Aegon completes sale of Central and Eastern European Businesses to VIG

Written by Customer Service on June 1, 2023. Posted in Mergers And Acquisitions.

The Hague, June 1, 2023 – Aegon today announces the completion of the divestment of its businesses in Poland and Romania to Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG) for EUR 125 million. This was the final step to complete the full sale of Aegon’s insurance, pension and asset management business in Central and Eastern Europe to VIG, following the closings of the divestments of the Hungarian and Turkish businesses. “We are very pleased that we have now finalized the full divestment of our Central and Eastern European businesses. As part of Aegon’s transformation and sharpened focus, the closing allows us to fully concentrate on the countries and business lines where we can add most value, while our former businesses will start their new chapter as part of VIG,” says Lard Friese, CEO of Aegon. “I would like to sincerely...

Sampo plc’s share buybacks 31/05/2023

Written by Customer Service on June 1, 2023. Posted in Public Companies.

SAMPO PLC STOCK EXCHANGE RELEASE 01/06/2023 at 08:30 am Sampo plc’s share buybacks 31/05/2023 On 31/05/2023 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code) 7,643 43.12 AQEU 27,383 43.04 CEUX 12,174 43.04 TQEX 72,800 43.03 XHELTOTAL 120,000 43.04 *rounded to two decimals On 29 March 2023, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 3 April 2023, is...

Correction: Unaudited financial results of “Vilvi Group“ for the first three months of 2023

Written by Customer Service on June 1, 2023. Posted in Public Companies.

Note: In the explanation of the results for the first quarter of 2023, the change in net profit is adjusted (from -37.6% to -51%). According to preliminary unaudited data, consolidated sales revenue of Vilvi Group for three months of 2023 amounted to 53.7 million EUR – 6.4 % increase comparing to the same period last year (sales revenue for the first three months of 2022 amounted to 50.4 million EUR). The Group earned 1.5 million EUR net profit over the first three months of 2023 or 51% less than in the same period last year (net profit for the first quarter of 2022 was EUR 3.044 million). Vilija Milaseviciute Economics and Finance Director Phone: +370 441 55 102AttachmentThe results of three months 2023

Nykode Therapeutics Announces Expansion of Clinical Collaboration with Roche to Evaluate VB10.16 in Combination with anti-PD-L1 in the next trial in Advanced Cervical Cancer

Written by Customer Service on June 1, 2023. Posted in Public Companies.

Potentially registrational trial with Nykode’s lead candidate VB10.16 and Roche’s atezolizumab (Tecentriq®) in the U.S. is expected to be initiated 4Q 2023 OSLO, Norway, June 01, 2023 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has expanded the clinical collaboration and supply agreement with Roche to cover evaluation of VB10.16, Nykode’s wholly owned off-the-shelf therapeutic cancer vaccine candidate, in combination with Roche’s cancer immunotherapy atezolizumab in patients with advanced cervical cancer who have progressed on pembrolizumab plus chemotherapy +/- bevacizumab as first line treatment. The VB-C-04 trial is expected to be initiated in the U.S. in the fourth quarter of 2023...

Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed

Written by Customer Service on June 1, 2023. Posted in Public Companies.

Ad hoc announcement pursuant to Art. 53 LR Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completedSchweiter Technologies is increasing its 40% minority holding by taking over the remaining 60% of the stock. The agreement to purchase the rest of the shares in JMB Wind Engineering (“JMB”) has been signed and completed, further strengthening the Core Materials business of 3A Composites.Steinhausen, 1 June 2023 – JMB (www.jmbwind.com) is a leading developer and producer of core material kits – primarily balsa and PET products for wind turbines. It is headquartered in Goleniów, Poland and has subsidiaries in Poland, Portugal and Brazil. The company acquired has approximately 430 employees and achieved sales of around EUR 70 million in the 2022 business year. Schweiter Technologies acquired a...

Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares

Written by Customer Service on June 1, 2023. Posted in Public Companies.

ZUG, Switzerland and BOSTON, May 31, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the pricing of a follow-on public offering of 3,500,000 ordinary shares at a public offering price of $11.50 per ordinary share, for gross proceeds of $40.25 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Oculis has granted the underwriters a 30-day option to purchase up to an additional 525,000 ordinary shares on the same terms and conditions. The offering is expected to close on or about June 5, 2023, subject to satisfaction of customary closing conditions. Oculis intends to use the net proceeds from this offering, together with its existing resources, to advance its development...

Nine Mile Metals Private Placement Financing

Written by Customer Service on June 1, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”) announces its intention to complete a private placement for proceeds of up to $250,000 (the “Private Placement”). The Private Placement will consist of the sale of up to 2,500,000 units (each a “Unit”) at a price of $0.10 per Unit. Each Unit will be comprised of one common share (a “Common Share”) and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a “Warrant“), with each Warrant entitling the holder thereof to acquire one Common Share in the capital of the Company at a price of $0.15 per Common Share for a period of 24 months from the date of issuance. In consideration for their services in introducing subscribers to the Company under...

SET Launches New Trading System Leveraging Nasdaq Technology to Meet End-to-End Investment Needs

Written by Customer Service on June 1, 2023. Posted in Public Companies.

BANGKOK, Thailand and NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — The Stock Exchange of Thailand (SET) has successfully launched its new trading system, together with market data distribution and market surveillance systems, based on Nasdaq (Nasdaq: NDAQ) technology. All systems are running seamlessly and operating at full efficiency in line with international standards and best practice. This newly developed state-of-the-art solution will support increasing transaction volumes and a variety of innovative investment products, whilst further enhancing the trust and integrity of the market. This implementation marks a significant milestone in the ongoing development of the modern Thai capital market, established to promote economic growth and stability, and to develop people’s standard of living. Today, SET has the highest liquidity...

HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock

Written by Customer Service on June 1, 2023. Posted in Public Companies.

NEW YORK and VIENNA, Austria, May 31, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (Nasdaq: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the pricing of an underwritten public offering of 22,900,768 shares of its common stock and 15,268 shares of its non-voting Series A-2 convertible preferred stock (the “Offering”). The public offering price of each share of common stock is $1.31 and the public offering price of each share of non-voting Series A-2 preferred stock is $1,310.00 (each share of non-voting Series A-2 preferred stock is convertible into 1,000 shares of common stock). The gross proceeds to HOOKIPA from this offering are expected to be approximately $50.0 million, before deducting underwriting discounts and commissions and other offering...

Day: June 1, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice